Latest News

Jeffrey P. Townsend, PhD, Elihu Professor of Biostatistics and professor of Ecology and Evolutionary Biology, co-leader, Genomics, Genetics, & Epigenetics Research Program, Yale School of Public Health, discusses analyses of driver mutations in prostate cancer driver using early neoplasm tissue samples to help characterize the molecular and genetic progress of the disease.

“When the study launched, even with operable pancreatic cancers, 90% of patients were still relapsing and dying from their cancer eventually,” said Dr. Michael Cecchini, the first author of the study and the co-director of the colorectal program at the Center for Gastrointestinal Cancers at Smilow Cancer Hospital and YCC. “We sought to move chemotherapy up in their treatment regimen and give it before surgery to see if we could improve the outcome for our patients.”

Yale School of Public Health researchers assessed how long international travelers should be quarantined to prevent COVID-19 infection rise, finding it differed quite a bit by country.

Yale Cancer Center researchers will present their new cancer research findings at the 2024 AACR annual meeting. A few of the presenting YCC researchers offer their key study takeaways and the significance for patients and oncologists.

Yale Cancer Center (YCC) and Smilow Cancer Hospital physicians and scientists will share new data for breakthrough and emerging cancer treatments as well as new discoveries in obesity, tobacco, evolution, and early onset cancers in early April at the American Association for Cancer Research (AACR) annual meeting.

Amanita phalloides, also known as “death caps,” are the source of most mushroom fatalities worldwide and the bane of unwary foragers. Mycologist Yen-Wen (Denny) Wang, a postdoc at Yale School of Public Health, recently discovered that death caps are capable of sexually reproducing either solo or with a mate.

Dr. Jeffrey Townsend on Yale Cancer Answers.

A new method from the Yale School of Public Health offers a way to analyze how mutations interact with each other to alter tumor development. The innovation should make it easier to develop targeted therapies that anticipate the evolutionary path of a cancer, then corner and eradicate it.

As COVID-19 becomes endemic in the U.S., it will likely settle into a seasonable rhythm like influenza, becoming most active during the colder months in northern climes and subsiding in summer, according to a new study by researchers at the Yale School of Public Health and the University of North Carolina at Charlotte.